Defense Award | SPE2DX22D0019 | NPV PHARM PRIME VENDOR

SPE2DX22D0019 - NPV PHARM PRIME VENDOR

Federal Contract Award Search » IDC Award

This IDC contract for Pharmaceuticals > Pharmaceutical Products was awarded in FY2022 on Sep 22, 2022 to Cencora by DLA Medical Directorate. There have been $1.6B in obligations to date with a ceiling value of $10B, showing a 16% burn rate so far on the contract. The contract was not competed under any preference program with 3 offers received. We expect a 9 year duration with ultimate completion date of Dec 30, 2031.

Cencora is a contractor located in PA, doing primarily Pharmaceuticals > Pharmaceutical Products work for Defense. The company receives $2.2B annually in federal awards (as of FY2020). Also, they have shown success winning IDC contracts concentrated mainly on a singular customer focused portfolio.

The Federal Government competes and awards an Indefinite Delivery Contract (IDC) to support requirements where the quantity and time of delivery are unknown. Typically referred to as Indefinite Delivery-Indefinite Quantity (IDIQ) contracts, the Government has the option of awarding a single or multiple award IDIQ. Once awarded, an IDIQ acts as a master agreement between the Federal Government and one or more contractors. On an as-needed basis, Federal buying organizations place orders, commonly referred to as Task Orders against an IDIQ, to purchase goods or services available through the IDIQ.

Read the full report


Contract Number
SPE2DX22D0019
Obligations to Date
$1.6B
Ceiling Value
$10B
Award Date
09/22/2022
Contract Type
IDC
Competition Set Aside Type
No set aside used

Buying Agency/Office
Defense»Defense Logistics Agency (DLA)»DLA Troop Support»DLA Medical Directorate


Win More Federal Business

Imagine a world where every report, every insight is tailored specifically to you. Our entire platform is configured around your past performance so that everything is relevant.

Collaboration Stack

All the Right Tools

Business Development & Pipeline Management

We start with the largest federal opportunity database, including forecasts and re-competes, and add layer a suite of pipeline management tools.

Personalized Markets

Our market-centric platform adds context to every pursuit. Every opportunity, every report, tailored specifically to you.

Award Research & Market Intelligence

Find gaps in the market, identify key competitors and teaming partners, evaluate performance, and analyze pathways to new business.

Start Your Free Account Today

That's right. It's free to get started with Federal Compass

Gain Full Access to This Report and...

Contract Opportunities

Pipeline Management

Award Research

Funding Analysis

Partner Identification

Industry and Market Intel

Agency Spending Trends

Competitive Insights

Create Free Account

Enjoy instant access to the Federal Compass platform

Task Order History

Task Order No. Contractor Obligations Effective Date
SPE2D823FBU61 AMERISOURCEBERGEN DRUG CORP $44k 12/19/2022
SPE2D823FBU52 AMERISOURCEBERGEN DRUG CORP $12.8k 12/19/2022
SPE2D823FBV29 AMERISOURCEBERGEN DRUG CORP $10.5k 12/19/2022
SPE2D823FBU34 AMERISOURCEBERGEN DRUG CORP $8.1k 12/19/2022
SPE2D823FBU54 AMERISOURCEBERGEN DRUG CORP $7.5k 12/19/2022
SPE2D823FBU31 AMERISOURCEBERGEN DRUG CORP $1.7k 12/19/2022
SPE2D823FBU50 AMERISOURCEBERGEN DRUG CORP $8.7k 12/19/2022
SPE2D823FBU38 AMERISOURCEBERGEN DRUG CORP $3.5k 12/19/2022
SPE2D823FBU64 AMERISOURCEBERGEN DRUG CORP $37.3k 12/19/2022
SPE2D823FBU35 AMERISOURCEBERGEN DRUG CORP $68.7k 12/19/2022
SPE2D823FBU46 AMERISOURCEBERGEN DRUG CORP $87.5k 12/19/2022
SPE2D823FBU56 AMERISOURCEBERGEN DRUG CORP $32.3k 12/19/2022
SPE2D823FBU37 AMERISOURCEBERGEN DRUG CORP $33.8k 12/19/2022
SPE2D823FBU25 AMERISOURCEBERGEN DRUG CORP $14.9k 12/19/2022
SPE2D823FBU33 AMERISOURCEBERGEN DRUG CORP $10.7k 12/19/2022
SPE2D823FBU57 AMERISOURCEBERGEN DRUG CORP $289.9k 12/19/2022
SPE2D823FBU30 AMERISOURCEBERGEN DRUG CORP $202.79 12/19/2022
SPE2D823FBU74 AMERISOURCEBERGEN DRUG CORP $25.2k 12/19/2022
SPE2D823FBU60 AMERISOURCEBERGEN DRUG CORP $1.1k 12/19/2022
SPE2D823FBU42 AMERISOURCEBERGEN DRUG CORP $0.03 12/19/2022

Contracting Resources